Resistance to Src inhibition alters the BRAF-mutant tumor secretome to promote an invasive phenotype and therapeutic escape through a FAK>p130Cas>c-Jun signaling axis.

Resistance to Src inhibition alters the BRAF-mutant tumor secretome to promote an invasive phenotype and therapeutic escape through a FAK>p130Cas>c-Jun signaling axis. — المؤلف: Kessler, Brittelle E — Oncogene 20190429

المؤلف
Kessler, Brittelle E
النشر
Oncogene 20190429
الوصف
2565-2579 p.
الموضوعات
Apoptosis؛ Cell Line, Tumor؛ Crk-Associated Substrate Protein؛ Dasatinib؛ Drug Resistance, Neoplasm؛ Focal Adhesion Kinase 1؛ Humans؛ Mutation